CD19 anticorps (PE)

N° du produit ABIN2704188

Détail du produit anti-CD19 anticorps (PE)

Antigène: CD19 (CD19 Molecule (CD19))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD19 est conjugé à/à la PE

Application: Flow Cytometry (FACS)

Attributs du produit: The clone 4G7 recognizes a 90- kDa CD19 antigen that is present on human B lymphocytes. The CD19 antigen is present on approximately 7 to 23 % of human peripheral blood lymphocytes at all stages of B cell maturation but is lost on terminally differentiated plasma cells. CD19 does not react with resting or activated T lymphocytes, granulocytes, or monocytes.

Purification: Purified

Pureté: >95 %

Classe de qualité: GMP Grade

Immunogène: Human CCL (chronic lymphocytic leukemia) cells

Clone: 4G7

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 25 μg/mL

Buffer: PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Détails sur CD19

Antigène: CD19 (CD19 Molecule (CD19))

Autre désignation: CD19 (CD19 Produits)

Synonymes: anticorps B4, anticorps CVID3, anticorps AW495831, anticorps CD19, anticorps CD19 molecule, anticorps CD19 antigen, anticorps CD19, anticorps Cd19

Sujet: The clone 4G7 recognizes a 90- kDa CD19 antigen that is present on human B lymphocytes. The CD19 antigen is present on approximately 7 to 23 % of human peripheral blood lymphocytes at all stages of B cell maturation but is lost on terminally differentiated plasma cells. CD19 does not react with resting or activated T lymphocytes, granulocytes, or monocytes.

NCBI Accession: NM_001770

UniProt: P15391

Pathways: Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway